Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46(5):304–11. https://doi.org/10.1097/OLQ.0000000000000972.
Article
PubMed
Google Scholar
Koumans EH, Markowitz LE, Berman SM, St Louis ME. A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis. Int J Gynaecol Obstet. 1999;67:S29–33. https://doi.org/10.1016/S0020-7292(99)00136-8.
Article
PubMed
Google Scholar
Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202(12):1907–15. https://doi.org/10.1086/657320.
Article
PubMed
PubMed Central
Google Scholar
Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012;9(6):e1001251. https://doi.org/10.1371/journal.pmed.1001251.
Article
PubMed
PubMed Central
Google Scholar
Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260–9. https://doi.org/10.1093/cid/civ298.
Article
PubMed
PubMed Central
Google Scholar
Alisoltani A, Manhanzva MT, Potgieter M, Balle C, Bell L, Ross E, Iranzadeh A, du Plessis M, Radzey N, McDonald Z, et al. Microbial function and genital inflammation in young South African women at high risk of HIV infection. Microbiome 2020;8:165. https://doi.org/10.1186/s40168-020-00932-8.
Skafte-Holm A, Humaidan P, Bernabeu A, Lledo B, Jensen JS, Haahr T. The association between vaginal dysbiosis and reproductive outcomes in sub-fertile women undergoing IVF-treatment: a systematic PRISMA review and meta-analysis. Pathogens. 2021;10(3):295.
Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14–22. https://doi.org/10.1016/0002-9343(83)91112-9.
Article
CAS
PubMed
Google Scholar
Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 2004;104(2):267–72. https://doi.org/10.1097/01.AOG.0000134783.98382.b0.
Article
PubMed
Google Scholar
Bilardi J, Walker S, McNair R, Mooney-Somers J, Temple-Smith M, Bellhouse C, et al. Women’s management of recurrent bacterial vaginosis and experiences of clinical care: a qualitative study. PLoS One. 2016;11(3):e0151794. https://doi.org/10.1371/journal.pone.0151794.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353(18):1899–911. https://doi.org/10.1056/NEJMoa043802.
Article
CAS
PubMed
Google Scholar
Fettweis JM, Serrano MG, Sheth NU, Mayer CM, Glascock AL, Brooks JP, et al. Species-level classification of the vaginal microbiome. BMC Genomics. 2012;13(Suppl 8):S17.
Article
Google Scholar
Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra152.
Article
Google Scholar
McKinnon LR, Achilles SL, Bradshaw CS, Burgener A, Crucitti T, Fredricks DN, et al. The evolving facets of bacterial vaginosis: Implications for HIV transmission. AIDS Res Hum Retroviruses. 2019;35(3):219–28. https://doi.org/10.1089/aid.2018.0304.
Article
PubMed
PubMed Central
Google Scholar
Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. PNAS USA. 2011;108(Suppl 1):4680–7. https://doi.org/10.1073/pnas.1002611107.
Article
PubMed
Google Scholar
Muzny CA, Taylor CM, Swords WE, Tamhane A, Chattopadhyay D, Cerca N, Schwebke JR. An updated conceptual model on the pathogenesis of bacterial vaginosis. J Infect Dis. 2019;220(9):1399–405. https://doi.org/10.1093/infdis/jiz342.
UK National Guideline for the management of Bacterial Vaginosis. 2012:1–15. https://www.bashhguidelines.org/media/1041/bv-2012.pdf.
Workowski KA, Bolan GA. Sexually transmitted disease treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-3):1–137.
Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258–72. https://doi.org/10.1177/0956462418785451.
Article
PubMed
Google Scholar
Vaginitis in nonpregnant patients. ACOG Practice Bulletin, Number 215. Obstet Gynecol. 2020;135(1):e1–e17.
Article
Google Scholar
Koumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis. 2002;35(Suppl 2):S152–72. https://doi.org/10.1086/342103.
Article
PubMed
Google Scholar
Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev. 2009;3:CD006055.
Google Scholar
Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis. 1993;167(3):783–4. https://doi.org/10.1093/infdis/167.3.783.
Article
CAS
PubMed
Google Scholar
Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193(11):1478–89. https://doi.org/10.1086/503780.
Article
PubMed
Google Scholar
Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dorffel Y, Scholze J, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97 e91–6.
Article
Google Scholar
Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM, et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis. 2013;56(6):777–86. https://doi.org/10.1093/cid/cis1030.
Article
CAS
PubMed
Google Scholar
Bradshaw CS, Brotman RM. Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure. BMC Infect Dis. 2015;15(1):292. https://doi.org/10.1186/s12879-015-1027-4.
Article
PubMed
PubMed Central
Google Scholar
Muzny CA, Laniewski P, Schwebke JR, Herbst-Kralovetz MM. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr Opin Infect Dis. 2020;33(1):59–65. https://doi.org/10.1097/QCO.0000000000000620.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, et al. Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. N Engl J Med. 2020;382(20):1906–15. https://doi.org/10.1056/NEJMoa1915254.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ratten LK, Plummer EL, Murray GL, Danielewski J, Fairley CK, Garland SM, et al. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study. BJOG. 2021;128(4):756–67. https://doi.org/10.1111/1471-0528.16430.
Article
CAS
PubMed
Google Scholar
Eren AM, Zozaya M, Taylor CM, Dowd SE, Martin DH, Ferris MJ. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One. 2011;6(10):e26732. https://doi.org/10.1371/journal.pone.0026732.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mandar R, Punab M, Borovkova N, Lapp E, Kiiker R, Korrovits P, et al. Complementary seminovaginal microbiome in couples. Res Microbiol. 2015;166(5):440–7. https://doi.org/10.1016/j.resmic.2015.03.009.
Article
PubMed
Google Scholar
Zozaya M, Ferris MJ, Siren JD, Lillis R, Myers L, Nsuami MJ, et al. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome. 2016;4(1):16. https://doi.org/10.1186/s40168-016-0161-6.
Article
PubMed
PubMed Central
Google Scholar
Plummer EL, Vodstrcil LA, Danielewski JA, Murray GL, Fairley CK, Garland SM, et al. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: acceptability, tolerability and impact on the genital microbiota of couples - a pilot study. PLoS One. 2018;13(1):e0190199. https://doi.org/10.1371/journal.pone.0190199.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muzny CA, Van Der Pol W, Lefkowitz E, Ghosh A, Li M, Redden D, et al. 2408 Genital microbiomes of women with recurrent bacterial vaginosis and their regular male sexual partner. J Clin Translat Sci. 2018;2(S1):13. https://doi.org/10.1017/cts.2018.78.
Article
Google Scholar
Vodstrcil LA, Walker SM, Hocking JS, Law M, Forcey DS, Fehler G, et al. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission. Clin Infect Dis. 2015;60(7):1042–53. https://doi.org/10.1093/cid/ciu1130.
Article
PubMed
Google Scholar
Plummer EL, Vodstrcil LA, Fairley CK, Tabrizi SN, Garland SM, Law MG, et al. Sexual practices have a significant impact on the vaginal microbiota of women who have sex with women. Sci Rep. 2019;9(1):19749. https://doi.org/10.1038/s41598-019-55929-7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17(8):e235–79. https://doi.org/10.1016/S1473-3099(17)30310-9.
Article
PubMed
Google Scholar
Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69(5):962–76. https://doi.org/10.1016/0002-9378(55)90095-8.
Article
CAS
PubMed
Google Scholar
Criswell BS, Ladwig CL, Gardner HL, Dukes CD. Haemophilus vaginalis: vaginitis by inoculation from culture. Obstet Gynecol. 1969;33(2):195–9.
CAS
PubMed
Google Scholar
Patterson JL, Stull-Lane A, Girerd PH, Jefferson KK. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology. 2010;156(Pt 2):392–9. https://doi.org/10.1099/mic.0.034280-0.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gardner HL, Dukes CD. Hemophilus vaginalis vaginitis. Ann N Y Acad Sci. 1959;83:280–9. https://doi.org/10.1111/j.1749-6632.1960.tb40901.x.
Article
CAS
PubMed
Google Scholar
Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978;298(26):1429–34. https://doi.org/10.1056/NEJM197806292982601.
Article
CAS
PubMed
Google Scholar
Dawson SG, Ison CA, Csonka G, Easmon CS. Male carriage of Gardnerella vaginalis. Br J Vener Dis. 1982;58(4):243–5. https://doi.org/10.1136/sti.58.4.243.
Article
CAS
PubMed
PubMed Central
Google Scholar
Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. Jama. 1985;254(8):1046–9. https://doi.org/10.1001/jama.1985.03360080058029.
Article
CAS
PubMed
Google Scholar
Vejtorp M, Bollerup AC, Vejtorp L, Fanoe E, Nathan E, Reiter A, et al. Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner. Br J Obstet Gynaecol. 1988;95(9):920–6. https://doi.org/10.1111/j.1471-0528.1988.tb06581.x.
Article
CAS
PubMed
Google Scholar
Mengel MB, Berg AO, Weaver CH, Herman DJ, Herman SJ, Hughes VL, et al. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract. 1989;28(2):163–71.
CAS
PubMed
Google Scholar
Moi H, Erkkola R, Jerve F, Nelleman G, Bymose B, Alaksen K, et al. Should male consorts of women with bacterial vaginosis be treated? Genitourin Med. 1989;65(4):263–8. https://doi.org/10.1136/sti.65.4.263.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vutyavanich T, Pongsuthirak P, Vannareumol P, Ruangsri RA, Luangsook P. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol. 1993;82(4 Pt 1):550–4.
CAS
PubMed
Google Scholar
Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med. 1997;73(4):267–70. https://doi.org/10.1136/sti.73.4.267.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schwebke J, Lensing S, Lee J, Muzny CA, Pontius A, Woznicki N, Aguin T, Sobel JD. Treatment of male sexual partners of women with bacterial vaginosis (BV); a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2021;73(3):e672–9.
Vodstrcil LA, Plummer EL, Doyle M, Fairley CK, McGuiness C, Bateson D, et al. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence. BMC Infect Dis. 2020;20(1):834. https://doi.org/10.1186/s12879-020-05563-w.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mehta SD. Systematic review of randomized trials of treatment of male sexual partners for improved bacterial vaginosis outcomes in women. Sex Transm Dis. 2012;39(10):822–30. https://doi.org/10.1097/OLQ.0b013e3182631d89.
Article
PubMed
Google Scholar
Potter J. Should sexual partners of women with bacterial vaginosis receive treatment? Br J Gen Pract. 1999;49(448):913–8.
CAS
PubMed
PubMed Central
Google Scholar
Amaya-Guio J, Viveros-Carreno DA, Sierra-Barrios EM, Martinez-Velasquez MY, Grillo-Ardila CF. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database Syst Rev. 2016;10:CD011701.
PubMed
Google Scholar
Larsson PG, Platz-Christensen JJ, Sundstrom E. Is bacterial vaginosis a sexually transmitted disease? Int J STD AIDS. 1991;2(5):362–4. https://doi.org/10.1177/095646249100200511.
Article
CAS
PubMed
Google Scholar
Bukusi EA, Cohen CR, Meier AS, Waiyaki PG, Nguti R, Njeri JN, et al. Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis. 2006;33(6):361–7. https://doi.org/10.1097/01.olq.0000200551.07573.df.
Article
PubMed
Google Scholar
Fethers KA, Fairley CK, Morton A, Hocking JS, Hopkins C, Kennedy LJ, et al. Early sexual experiences and risk factors for bacterial vaginosis. J Infect Dis. 2009;200(11):1662–70. https://doi.org/10.1086/648092.
Article
PubMed
Google Scholar
Fethers KA, Fairley CK, Morton A, Hocking JS, Fehler G, Kennedy LJ, et al. Low incidence of bacterial vaginosis in cohort of young Australian women. Sex Transm Dis. 2011;38(2):124–6. https://doi.org/10.1097/OLQ.0b013e3181f0bc37.
Article
PubMed
Google Scholar
Vodstrcil LA, Twin J, Garland SM, Fairley CK, Hocking JS, Law MG, et al. The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women. PLoS One. 2017;12(2):e0171856. https://doi.org/10.1371/journal.pone.0171856.
Article
CAS
PubMed
PubMed Central
Google Scholar
Francis SC, Crucitti T, Smekens T, Hansen CH, Andreasen A, Jespers V, et al. The vaginal microbiota among adolescent girls in Tanzania around the time of sexual debut. Front Cell Infect Microbiol. 2020;10:305. https://doi.org/10.3389/fcimb.2020.00305.
Article
PubMed
PubMed Central
Google Scholar
Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis. 2008;47(11):1426–35. https://doi.org/10.1086/592974.
Article
PubMed
Google Scholar
Warner L, Newman DR, Austin HD, Kamb ML, Douglas JM Jr, Malotte CK, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol. 2004;159(3):242–51. https://doi.org/10.1093/aje/kwh044.
Article
PubMed
Google Scholar
Forcey DS, Vodstrcil LA, Hocking JS, Fairley CK, Law M, McNair RP, et al. Factors associated with bacterial vaginosis among women who have sex with women: A systematic review. PLoS One. 2015;10(12):e0141905. https://doi.org/10.1371/journal.pone.0141905.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schwebke J, Desmond RA. Risk Factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis. 2005;32(11):654–8. https://doi.org/10.1097/01.olq.0000175396.10304.62.
Article
PubMed
Google Scholar
Marrazzo JM, Thomas KK, Fiedler TL, Ringwood K, Fredricks DN. Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study. PLoS One. 2010;5(6):e11139. https://doi.org/10.1371/journal.pone.0011139.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hutchinson KB, Kip KE, Ness RB. Condom use and its association with bacterial vaginosis and bacterial vaginosis-associated vaginal microflora. Epidemiology. 2007;18(6):702–8. https://doi.org/10.1097/EDE.0b013e3181567eaa.
Article
PubMed
Google Scholar
Gallo MF, Warner L, King CC, Sobel JD, Klein RS, Cu-Uvin S, et al. Association between semen exposure and incident bacterial vaginosis. Infect Dis Obstet Gynecol. 2011;2011:842652.
PubMed
PubMed Central
Google Scholar
Muzny CA, Schwebke JR. Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure. Sex Transm Dis. 2014;41(1):58–60. https://doi.org/10.1097/OLQ.0000000000000057.
Article
PubMed
Google Scholar
Plummer EL, Vodstrcil LA, Murray GL, Fairley CK, Danielewski JA, Garland SM, et al. Gardnerella vaginalis clade distribution is associated with behavioural practices and Nugent Score in women who have sex with women. J Infect Dis. 2020;221(3):454–63. https://doi.org/10.1093/infdis/jiz474.
Article
PubMed
Google Scholar
Muzny CA, Blanchard E, Taylor CM, Aaron KJ, Talluri R, Griswold ME, et al. Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study. J Infect Dis. 2018;218(6):966–78. https://doi.org/10.1093/infdis/jiy243.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muzny CA, Lensing SY. Aaron KJ. Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women. Sex Transm Infect: Schwebke JR; 2019.
Google Scholar
Berger BJ, Kolton S, Zenilman JM, Cummings MC, Feldman J, McCormack WM. Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin Infect Dis. 1995;21(6):1402–5. https://doi.org/10.1093/clinids/21.6.1402.
Article
CAS
PubMed
Google Scholar
Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis. 2002;185(9):1307–13. https://doi.org/10.1086/339884.
Article
PubMed
Google Scholar
Bradshaw CS, Walker SM, Vodstrcil LA, Bilardi JE, Law M, Hocking JS, et al. The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study. J Infect Dis. 2014;209(10):1562–72. https://doi.org/10.1093/infdis/jit664.
Article
PubMed
Google Scholar
Marrazzo JM, Antonio M, Agnew K, Hillier SL. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis. 2009;199(5):680–3. https://doi.org/10.1086/596632.
Article
PubMed
Google Scholar
Vodstrcil LA, Plummer ME, Fairley CK, Tachedjian G, Law MG, Hocking JS, et al. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial. Sci Rep. 2019;9(1):3555. https://doi.org/10.1038/s41598-019-39879-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol. 2004;191(6):1898–906. https://doi.org/10.1016/j.ajog.2004.06.089.
Article
CAS
PubMed
Google Scholar
Schwebke JR, Desmond RA. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis. 2007;44(2):213–9. https://doi.org/10.1086/509577.
Article
CAS
PubMed
Google Scholar
Piot P, Van Dyck E, Peeters M, Hale J, Totten PA, Holmes KK. Biotypes of Gardnerella vaginalis. J Clin Microbiol. 1984;20(4):677–9. https://doi.org/10.1128/jcm.20.4.677-679.1984.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nelson DE, Dong Q, Van Der Pol B, Toh E, Fan B, Katz BP, et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One. 2012;7(5):e36298. https://doi.org/10.1371/journal.pone.0036298.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu CM, Hungate BA, Tobian AA, Ravel J, Prodger JL, Serwadda D, et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. MBio. 2015;6(3):e00589. https://doi.org/10.1128/mBio.00589-15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Plummer EL, Vodstrcil LA, Fairley CK, Danielewski JA, Murray GL, Doyle M, et al. The impact of concurrent partner treatment for bacterial vaginosis on the genital microbiota of heterosexual couples: A pilot study. Sex Transm Infect. 2021;97(Suppl 1):A18.
Google Scholar
Swidsinski A, Doerffel Y, Loening-Baucke V, Swidsinski S, Verstraelen H, Vaneechoutte M, et al. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest. 2010;70(4):256–63. https://doi.org/10.1159/000314015.
Article
PubMed
Google Scholar
Swidsinski A, Dorffel Y, Loening-Baucke V, Mendling W, Verstraelen H, Dieterle S, et al. Desquamated epithelial cells covered with a polymicrobial biofilm typical for bacterial vaginosis are present in randomly selected cryopreserved donor semen. FEMS Immunol Med Microbiol. 2010;59(3):399–404. https://doi.org/10.1111/j.1574-695X.2010.00688.x.
Article
CAS
PubMed
Google Scholar
Gray RH, Wawer MJ, Serwadda D, Kigozi G. The role of male circumcision in the prevention of human papillomavirus and HIV infection. J Infect Dis. 2009;199(1):1–3. https://doi.org/10.1086/595568.
Article
PubMed
Google Scholar
Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, Bowers J, et al. The effects of circumcision on the penis microbiome. PLoS One. 2010;5(1):e8422. https://doi.org/10.1371/journal.pone.0008422.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu CM, Hungate BA, Tobian AA, Serwadda D, Ravel J, Lester R, et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. MBio. 2013;4(2):e00076. https://doi.org/10.1128/mBio.00076-13.
Article
PubMed
PubMed Central
Google Scholar
Mehta SD, Zhao D, Green SJ, Agingu W, Otieno F, Bhaumik R, Bhaumik D, Bailey RC. The microbiome composition of a man’s penis predicts incident bacterial vaginosis in his female sex partner with high accuracy. Frontiers in Cellular and Infection Microbiology 2020;10:433. https://doi.org/10.3389/fcimb.2020.00433.
Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1795–806. https://doi.org/10.1016/S0140-6736(13)61947-9.
Article
PubMed
PubMed Central
Google Scholar
Tanton C, Geary RS, Clifton S, Field N, Heap KL, Mapp F, et al. Sexual health clinic attendance and non-attendance in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect. 2018;94(4):268–76. https://doi.org/10.1136/sextrans-2017-053193.
Article
PubMed
Google Scholar
Muzny CA, Pontius A, Woznicki N, Hudak KE, Lensing SY, Sobel JD, et al. Use of a novel couples’ verification tool in a male partner treatment study of women with recurrent bacterial vaginosis. Sex Transm Dis. 2020;47(12):e58–61. https://doi.org/10.1097/OLQ.0000000000001225.
Article
PubMed
Google Scholar
Weinhardt LS, Forsyth AD, Carey MP, Jaworski BC, Durant LE. Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Arch Sex Behav. 1998;27(2):155–80. https://doi.org/10.1023/A:1018682530519.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26(2):104–23. https://doi.org/10.1207/S15324796ABM2602_03.
Article
PubMed
Google Scholar
Tourangeau R, Yan T. Sensitive questions in surveys. Psychol Bull. 2007;133(5):859–83. https://doi.org/10.1037/0033-2909.133.5.859.
Article
PubMed
Google Scholar
DiClemente RJ, Sales JM, Danner F, Crosby RA. Association between sexually transmitted diseases and young adults’ self-reported abstinence. Pediatrics. 2011;127(2):208–13. https://doi.org/10.1542/peds.2009-0892.
Article
PubMed
PubMed Central
Google Scholar
Wigan R, Vaughn C, Vodstrcil L, Doyle M, Kaiser M, McGuiness C, et al. “It’s just an issue and you deal with it... you just deal with it, you move on and you do it together.”: Men’s experiences of bacterial vaginosis and the acceptability of male partner treatment. PLoS One. 2020;15(6):e0235286.
Article
CAS
Google Scholar
Lofmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50(Suppl 1):S16–23. https://doi.org/10.1086/647939.
Article
CAS
PubMed
Google Scholar
Sobel R, Sobel JD. Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother. 2015;16(7):1109–15. https://doi.org/10.1517/14656566.2015.1035255.
Article
CAS
PubMed
Google Scholar
Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol. 2004;191(4):1124–9. https://doi.org/10.1016/j.ajog.2004.05.033.
Article
PubMed
Google Scholar
Kharsany AB, Hoosen AA, Van den Ende J. Antimicrobial susceptibilities of Gardnerella vaginalis. Antimicrob Agents Chemother. 1993;37(12):2733–5. https://doi.org/10.1128/AAC.37.12.2733.
Article
CAS
PubMed
PubMed Central
Google Scholar
Simoes JA, Aroutcheva A, Heimler I, Shott S, Faro S. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility. Am J Obstet Gynecol. 2001;185(5):1186–90. https://doi.org/10.1067/mob.2001.118144.
Article
CAS
PubMed
Google Scholar
Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis. 2004;4(1):5. https://doi.org/10.1186/1471-2334-4-5.
Article
PubMed
PubMed Central
Google Scholar
De Backer E, Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Temmerman M, et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis. 2006;6(1):51. https://doi.org/10.1186/1471-2334-6-51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nagaraja P. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis. Indian J Med Microbiol. 2008;26(2):155–7. https://doi.org/10.4103/0255-0857.40531.
Article
CAS
PubMed
Google Scholar
Alves P, Castro J, Sousa C, Cereija TB, Cerca N. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. J Infect Dis. 2014;210(4):593–6. https://doi.org/10.1093/infdis/jiu131.
Article
PubMed
Google Scholar
Schuyler JA, Mordechai E, Adelson ME, Sobel JD, Gygax SE, Hilbert DW. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn Microbiol Infect Dis. 2016;84(1):1–3. https://doi.org/10.1016/j.diagmicrobio.2015.10.006.
Article
CAS
PubMed
Google Scholar
Swidsinski A, Dorffel Y, Loening-Baucke V, Schilling J, Mendling W. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment. FEMS Immunol Med Microbiol. 2010;61(1):41–6. https://doi.org/10.1111/j.1574-695X.2010.00743.x.
Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it's associated resistance patterns. Microb Pathog. 2019;127:21–30. https://doi.org/10.1016/j.micpath.2018.11.046.
Article
PubMed
Google Scholar
Lee CY, Cheu RK, Lemke MM, Gustin AT, France MT, Hampel B, et al. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis. Nat Commun. 2020;11(1):6147. https://doi.org/10.1038/s41467-020-19880-w.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schwebke JR, Morgan FG, Jr., Koltun W, Nyirjesy P: A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol. 2017;217(6):e678.e1–678.e9.
De Backer E, Dubreuil L, Brauman M, Acar J, Vaneechoutte M. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clin Microbiol Infect. 2010;16(5):470–2. https://doi.org/10.1111/j.1469-0691.2009.02852.x.
Article
PubMed
Google Scholar
Petrina MAB, Cosentino LA, Rabe LK, Hillier SL. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe. 2017;47:115–9. https://doi.org/10.1016/j.anaerobe.2017.05.005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li T, Zhang Z, Wang F, He Y, Zong X, Bai H, et al. Antimicrobial susceptibility testing of metronidazole and clindamycin against Gardnerella vaginalis in planktonic and biofilm formation. Can J Infect Dis Med Microbiol. 2020;2020:1361825.
PubMed
PubMed Central
Google Scholar
Sobel JD, Sobel R. Current and emerging pharmacotherapy for recurrent bacterial vaginosis. Expert Opin Pharmacother. 2021; Ahead of print:1–8. https://doi.org/10.1080/14656566.2021.1904890.
Gaspar C, Rolo J, Cerca N, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Palmeira-de-Oliveira A. Dequalinium chloride effectively disrupts bacterial vaginosis (BV) Gardnerella spp. biofilms. Pathogens. 2021;10(3):261.
Marrazzo JM, Dombrowski JC, Wierzbicki MR, Perlowski C, Pontius A, Dithmer D, et al. Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, single-blind, phase 2, controlled trial. Clin Infect Dis. 2019;68(5):803–9. https://doi.org/10.1093/cid/ciy554.
Article
CAS
PubMed
Google Scholar
Galiwango RM, Bagaya B, Mpendo J, Joag V, Okech B, Nanvubya A, et al. Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men. Trials. 2019;20(1):443. https://doi.org/10.1186/s13063-019-3545-7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muzny CA, Schwebke JR. Asymptomatic bacterial vaginosis: to treat or not to treat? Curr Infect Dis Rep. 2020;22(12):32.
U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Bacterial Vaginosis: Developing Drugs for Treatment, Guidance for Industry. 2019.
Hillier SL, Nyirjesy P, Waldbaum AS, Schwebke JR, Morgan FG, Adetoro NA, et al. Secnidazole treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2017;130(2):379–86. https://doi.org/10.1097/AOG.0000000000002135.
Article
CAS
PubMed
Google Scholar
Machado D, Castro J, Palmeira-de-Oliveira A, Martinez-de-Oliveira J, Cerca N. Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions. Front Microbiol. 2015;6:1528.
PubMed
Google Scholar
Muzny CA, Schwebke JR. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin Infect Dis. 2015;61(4):601–6. https://doi.org/10.1093/cid/civ353.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bradshaw CS, Sobel JD. Current treatment of bacterial vaginosis: limitations and need for innovation. J Infect Dis. 2016;214(Suppl 1):S14–20. https://doi.org/10.1093/infdis/jiw159.
Article
PubMed
PubMed Central
Google Scholar
Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med. 2019;25(10):1500–4. https://doi.org/10.1038/s41591-019-0600-6.
Article
CAS
PubMed
Google Scholar
DeLong K, Bensouda S, Zulfiqar F, Zierden HC, Hoang TM, Abraham AG, et al. Conceptual design of a universal donor screening approach for vaginal microbiota transplant. Front Cell Infect Microbiol. 2019;9:306. https://doi.org/10.3389/fcimb.2019.00306.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9-10):782–92. https://doi.org/10.1016/j.resmic.2017.04.001.
Article
CAS
PubMed
Google Scholar
Armstrong-Buisseret L, Brittain C, David M, Dean G, Griffiths F, Hepburn T, et al. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis. Trials. 2019;20(1):648. https://doi.org/10.1186/s13063-019-3731-7.
Article
CAS
PubMed
PubMed Central
Google Scholar